Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 41 ~ 60 of 25572, Page 3 of 1280
41. FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
Approval Marks 14 th Indication for KEYTRUDA
11/09/2018 MERCK
42. Cigarette Smoking at Record Low Among American Adults
The percentage of American cigarette smokers in 2017 hit 14%, its lowest point since the National Health Interview Survey (NHIS) first started tracking smoking statistics in 1965.
11/09/2018 American Cancer Society
43. Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019
DUBLIN - November 9, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2019 on Tuesday, November 20, 2018. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com. The news release will include summary financial information for the company''s second quarter of fiscal year 2019, which ended on Friday, October 26, 2018.
11/09/2018 Medtronic
44. New Data from Investigational Study of LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination in Three Different Tumor Types Presented at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
First presentation of LENVIMA and KEYTRUDA combination data in patients with metastatic non-small cell lung cancer, metastatic melanoma and metastatic urothelial carcinoma from Study 111/KEYNOTE-146 New data support ongoing broad clinical program for LENVIMA and KEYTRUDA combination across multiple tumor types
11/09/2018 MERCK
45. FDA seizes food and medical products held under insanitary conditions at an Arkansas grocery warehouse
11/09/2018 U.S. FOOD & DRUG ADMINISTRATION
46. Medtronic Begins Renal Denervation Study for High Blood Pressure Patients Prescribed Anti-Hypertensive Medication
FDA-Approved Study Furthers Medtronic Commitment to Generate Meaningful Clinical Evidence for Use of Renal Denervation to Treat Uncontrolled Hypertension
11/08/2018 Medtronic
47. Cigarette Smoking Among U.S. Adults Lowest Ever Recorded: 14% in 2017
Cigarette smoking has reached the lowest level ever recorded among U.S. adults, according to new data published by the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health’s National Cancer Institute (NCI). Still, about 47 million (1 in 5) U.S. adults used a tobacco product in 2017, and they used a variety of smoked, smokeless, and electronic tobacco products.
11/08/2018 Centers for Disease Control and Prevention
48. International Day of Radiology Recognizes Medical Imaging Contributions
11/08/2018 Radiological Society of North America
49. Early Phase 1 Data from Merck’s Oncology Pipeline for Investigational Anti-LAG-3 Therapy (MK-4280) and Anti-TIGIT Therapy (MK-7684) to Be Presented at SITC’s 33rd Annual Meeting
With New Data, Merck Now has Presented Early Clinical Data for Six Investigational Oncology Pipeline Candidates Spanning Several Pathways
11/07/2018 MERCK
50. Medtronic Presents IN.PACT SFA Trial Five-Year Data and Total IN.PACT All-Subjects Analysis in VIVA Late Breaking Clinical Trials
(GLOBE NEWSWIRE via COMTEX) --New Data Continue to Reinforce IN.PACT Admiral DCB as a Durable, Frontline Option to Address Treatment Challenges in PAD
11/06/2018 Medtronic
51. Artificial Intelligence Predicts Alzheimer''s Years Before Diagnosis
OAK BROOK, Ill. ? Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer''s disease, according to a study published in the journal Radiology.
11/06/2018 Radiological Society of North America
52. American Joint Replacement Registry (AJRR) Releases 2018 Annual Report
Data shows continuity of hip and arthroplasty trends, and the value of more complete information for early survival analysis of primary arthroplasty
11/02/2018 American Academy of Orthopaedic Surgeons
53. Top stories: the appendix"s secret seeds, earthquake warnings, and a halted heart repair trial
We tend to ignore the appendix unless it gets inflamed and needs cutting out. But a new study suggests this enigmatic organ in the gut harbors a supply of a brain, damaging protein involved in Parkinson''s disease뾢ven in healthy people.
11/02/2018 Science by Frankie Schembri
54. AMA Applauds HHS for Revisions to Medicare E/M Policies
The AMA applauded HHS efforts to rein in documentation requirements that interfere with the patient-physician relationship.
11/01/2018 American Medical Association (AMA)
55. Electrical spinal cord stimulation must preserve proprioception to enable locomotion in humans with spinal cord injury
The combination of spinal epidural stimulation and physical therapy is restoring walking function to people with spinal cord injury. With intensive rehabilitation, some participants are able to walk in their communities during stimulation and even regain control over previously paralyzed movement in the absence of stimulation.
10/31/2018 Nature Neuroscience (2018)
56. FDA Approves Merck"s KEYTRUDA® (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Approval Based on Results of Phase 3 KEYNOTE-407 Trial, Which Demonstrated Superior Overall Survival with KEYTRUDA in Combination with Chemotherapy Compared to Chemotherapy Alone First Anti-PD-1 Approved for First-Line Treatment of Squamous NSCLC Regardless of PD-L1 Expression
10/30/2018 MERCK
57. New $15 Million Initiative to Further Reimagine Physician Training
New AMA Reimagining Residency initiative is aimed at transforming residency training to ensure physician well-being and improved patient safety.
10/30/2018 American Medical Association (AMA)
58. More than 90% of the world’s children breathe toxic air every day
Every day around 93% of the world’s children under the age of 15 years (1.8 billion children) breathe air that is so polluted it puts their health and development at serious risk. Tragically, many of them die: WHO estimates that in 2016, 600,000 children died from acute lower respiratory infections caused by polluted air.
10/29/2018 World Health Organization (WHO)
59. Relying on Dr. Google to Diagnose Eye Problems may be Dangerous to Your Health
Study shows popular online symptom checker was incorrect 74 percent of the time, often assesses symptom severity incorrectly.
10/29/2018 American Academy of Ophthalmology
60. Unapproved Therapies Cause Significantly More Patient Injuries Than Reported by Cell Therapy Clinics
A team of ophthalmologists went looking for scientific evidence in support of commercially available “cell therapy” for eye diseases. Not only did they find virtually none; they instead discovered a growing number of patients are being irreparably harmed by unapproved cell therapies.
10/29/2018 American Academy of Ophthalmology
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱